Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/1999
09/02/1999WO1999043841A1 Self-replicating vector for dna immunization against hiv
09/02/1999WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/02/1999WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same
09/02/1999WO1999043838A1 Synthetic promoters
09/02/1999WO1999043837A1 Conversion and removal of steroid glycoalkaloids
09/02/1999WO1999043836A1 Banana streak virus promoter and detection
09/02/1999WO1999043835A2 Methods for producing a polypeptide in a bacillus cell
09/02/1999WO1999043833A1 Disease resistant transgenic plants
09/02/1999WO1999043832A2 Human proteinase molecules
09/02/1999WO1999043831A1 Cprot03, a human cysteine protease
09/02/1999WO1999043830A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
09/02/1999WO1999043829A2 Cell cycle related proteins
09/02/1999WO1999043828A1 Human homolog of the drosophila protein 'fused'
09/02/1999WO1999043827A1 Cyclopropane-fatty-acyl-phospholipid synthase
09/02/1999WO1999043826A1 A gene involved in thiophene degradation from nocardia asteroides kgb1
09/02/1999WO1999043825A1 Plant flavanone-3-hydroxylase
09/02/1999WO1999043824A1 Cultivar specificity gene from the rice pathogen magnaporthe grisea, and methods of use
09/02/1999WO1999043823A1 Methods for enhancing disease resistance in plants
09/02/1999WO1999043822A1 Nitric oxide as an activator of the plant pathogen defense systems
09/02/1999WO1999043821A1 Genes for activation of plant pathogen defense systems
09/02/1999WO1999043820A1 PLANT TRANSLATION FACTOR eIF-4E
09/02/1999WO1999043819A1 Family of maize pr-1 genes and promoters
09/02/1999WO1999043818A1 Novel dna fragments ordering gene expression predominant in flower organ
09/02/1999WO1999043817A1 High affinity humanized anti-cea monoclonal antibodies
09/02/1999WO1999043816A1 High affinity humanized anti-tag-72 monoclonal antibodies
09/02/1999WO1999043815A2 Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
09/02/1999WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
09/02/1999WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
09/02/1999WO1999043812A2 Dlc-1 gene, a putative tumors suppressor gene
09/02/1999WO1999043811A1 cDNA ENCODING A GENE BOG (B5T OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT
09/02/1999WO1999043810A1 Mutant heparin cofactor ii
09/02/1999WO1999043809A2 Protease-activated receptor 4 and uses thereof
09/02/1999WO1999043808A1 Human c-maf compositions and methods of use thereof
09/02/1999WO1999043807A2 Human channel-related molecules
09/02/1999WO1999043806A1 Human smn-like protein
09/02/1999WO1999043805A1 Human protein kinase c inhibitor
09/02/1999WO1999043804A1 Mouse tcf-3 and tcf-4 and tumourigenesis related to wnt/wingless signalling
09/02/1999WO1999043803A1 Genomic gene encoding hm1.24 antigen protein and promoter thereof
09/02/1999WO1999043802A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
09/02/1999WO1999043801A1 Anti-angiogenic vaccines: substances and methods relating thereto
09/02/1999WO1999043800A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72
09/02/1999WO1999043799A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disrupting substance or its degradation product and utilization of the same
09/02/1999WO1999043797A2 Constitutive maize promoters
09/02/1999WO1999043796A1 Methods of using a pathogen-activatable map kinase to enhance disease resistance in plants
09/02/1999WO1999043795A1 Trans-somatics with gene transfer into mammary epithelial cells
09/02/1999WO1999043794A1 Maltogenic alpha-amylase variants
09/02/1999WO1999043792A1 Recombinant protein having rna-dependent polymerase activity of human hepatitis c virus and process for producing the same
09/02/1999WO1999043791A2 Diisopropyl fluorophosphatase and the utilization and production thereof
09/02/1999WO1999043789A1 Efficient aav vectors
09/02/1999WO1999043783A2 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER
09/02/1999WO1999043752A1 Compositions for transporting negatively charged substances
09/02/1999WO1999043713A1 Enhancing the circulating half-life of antibody-based fusion proteins
09/02/1999WO1999043710A1 Prostate-specific membrane antigens and methods of making and using
09/02/1999WO1999043707A1 N-terminally modified glp-1 derivatives
09/02/1999WO1999043705A1 N-terminally truncated glp-1 derivatives
09/02/1999WO1999043703A1 Method for immunochemically assaying anti-hm1.24 antibody
09/02/1999WO1999043702A1 PROTEIN BINDING TO NE-dlg
09/02/1999WO1999043697A1 Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
09/02/1999WO1999043695A1 Best's macular dystrophy gene
09/02/1999WO1999043693A1 36 human secreted proteins
09/02/1999WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
09/02/1999WO1999043688A1 Photoactivatable nucleic acid derivatives
09/02/1999WO1999043434A1 System and method of aspirating and dispensing reagent
09/02/1999WO1999043350A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
09/02/1999WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
09/02/1999WO1999043208A1 The helios gene
09/02/1999WO1999043202A1 PARTICLE BOMBARDMENT TRANSFORMATION OF $i(BRASSICA)
09/02/1999WO1999037795B1 PROMOTER AND REGULATOR SEQUENCES Ha ds10 G1: A GENE LEA OF SUNFLOWER EXPRESSED EXCLUSIVELY IN SEEDS FROM THE MATURATION PHASE
09/02/1999WO1999033958A3 Desaturase
09/02/1999WO1999033488A3 Adjuvanted vaccine formulation
09/02/1999WO1999031240A3 14-3-3σ ARRESTS THE CELL CYCLE
09/02/1999WO1999029903A3 Cancer susceptibility mutations of brca1
09/02/1999WO1999028485A3 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes
09/02/1999WO1999028453A3 Transgenic non-human mammals with an oncogenic mutant of raf gene 1
09/02/1999WO1999027109A3 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
09/02/1999WO1999023209A3 ErbB-4 TARGETED RIBOZYMES
09/02/1999WO1999023116A9 ASSAY EMPLOYING CadC FUSION PROTEINS
09/02/1999WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth
09/02/1999WO1999022772A9 LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS FOR MODULATING ras GENE EXPRESSION
09/02/1999WO1999020770A3 Multiply-substituted protease variants
09/02/1999WO1999020766A3 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
09/02/1999WO1999020723A9 Multiply-substituted protease variant and amylase variant-containing cleaning compositions
09/02/1999WO1999019357A9 Cell regulatory genes, encoded products, and uses related thereto
09/02/1999WO1999019348A8 Laminins and uses thereof
09/02/1999WO1999015548B1 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
09/02/1999WO1999010498A3 Genes encoding enzymes for lignin biosynthesis and uses thereof
09/02/1999WO1999002711A3 Fusion proteins with an immunoglobulin hinge region linker
09/02/1999WO1998040052A9 Cationic lipid compositions targeting angiogenic endothelial cells
09/02/1999WO1998033917A9 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/02/1999WO1998030693A9 Tumor necrosis factor receptor 5
09/02/1999CA2792479A1 Vaccines, immunotherapeutics and methods for using the same
09/02/1999CA2759907A1 Maltogenic alpha-amylase variants
09/02/1999CA2627799A1 Tumor tissue microarrays for rapid molecular profiling
09/02/1999CA2440416A1 Particle bombardment transformation of brassica
09/02/1999CA2354228A1 Plants and seeds containing synthetic promoters
09/02/1999CA2322711A1 Human proteins having transmembrane domains and dnas encoding these proteins
09/02/1999CA2322206A1 Methods and apparatus for determination of length polymorphisms in dna
09/02/1999CA2322160A1 Vaccines, immunotherapeutics and methods for using the same
09/02/1999CA2322070A1 Protein binding to ne-dlg
09/02/1999CA2322066A1 A simplified system for generating recombinant adenoviruses